SAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INC

SAREPTA THERAPEUTICS INC

No trades
See on Supercharts

Price target

3,755.580.000.00%
The 20 analysts offering 1 year price forecasts for SRPT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 22 analysts giving stock ratings to SRPT in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SRPT EPS for the last quarter is 6.70 MXN despite the estimation of −1.49 MXN. In the next quarter EPS is expected to reach 39.74 MXN. Track more of SAREPTA THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter SAREPTA THERAPEUTICS INC revenue is expected to reach ‪13.05 B‬ MXN. Check out SAREPTA THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, SRPT price target is 3,755.58 MXN with a max estimate of 4,401.62 MXN and a min estimate of 1,521.30 MXN. Check if this forecast comes true in a year, meanwhile watch SAREPTA THERAPEUTICS INC stock price chart and keep track of the current situation with SRPT news and stock market news.
We've gathered opinions of 22 analysts rating SRPT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.